Biotechnology company Amgen has reached a deal to buy all outstanding shares of California-based Onyx Pharmaceuticals for $125 per share in cash. The purchase price of the transaction that is expected to be closed by the beginning of ...
Tags: Amgen, Onyx Pharmaceuticals
Onyx Pharmaceuticals, a licensee of Ligand Pharmaceuticals, has gained FDA approval for Kyprolis (carfilzomib) for injection. Kyprolis is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have ...
Tags: Onyx Pharmaceuticals, Ligand Pharmaceuticals, Kyprolis